Literature DB >> 33206315

Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.

Vladimir J Balcar1,2, Tomáš Zeman3,4, Vladimír Janout5,6, Jana Janoutová5,6, Jan Lochman3,4, Omar Šerý3,4.   

Abstract

Clusterin (CLU; also known as apolipoprotein J, ApoJ) is a protein of inconstant structure known to be involved in diverse processes inside and outside of brain cells. CLU can act as a protein chaperon or protein solubilizer, lipid transporter as well as redox sensor and be anti- or proapoptotic, depending on context. Primary structure of CLU is encoded by CLU gene which contains single nucleotide polymorphisms (SNP's) associated with the risk of late-onset Alzheimer's disease (LOAD). Studying a sample of Czech population and using the case-control association approach we identified C allele of the SNP rs11136000 as conferring a reduced risk of LOAD, more so in females than in males. Additionally, data from two smaller subsets of the population sample suggested a possible association of rs11136000 with diabetes mellitus. In a parallel study, we found no association between rs11136000 and mild cognitive impairment (MCI). Our findings on rs11136000 and LOAD contradict those of some previous studies done elsewhere. We discuss the multiple roles of CLU in a broad range of molecular mechanisms that may contribute to the variability of genetic studies of CLU in various ethnic groups. The above discordance notwithstanding, our conclusions support the association of rs1113600 with the risk of LOAD.

Entities:  

Keywords:  Clusterin; Genetic risk; Late-onset Alzheimer’s disease; Mild cognitive impairment; Neurodegeneration; Neuroprotection; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2020        PMID: 33206315     DOI: 10.1007/s11064-020-03176-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  63 in total

Review 1.  Perspectives in genetic prediction of Alzheimer's disease.

Authors:  Omar Šerý; Jana Povová; Vladimir J Balcar
Journal:  Neuro Endocrinol Lett       Date:  2014       Impact factor: 0.765

2.  CD36 gene polymorphism is associated with Alzheimer's disease.

Authors:  Omar Šerý; Jana Janoutová; Laura Ewerlingová; Alice Hálová; Jan Lochman; Vladimír Janout; Naim A Khan; Vladimir J Balcar
Journal:  Biochimie       Date:  2017-01-20       Impact factor: 4.079

Review 3.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

Review 4.  Epidemiological of and risk factors for Alzheimer's disease: a review.

Authors:  Jana Povova; Petr Ambroz; Michal Bar; Veronika Pavukova; Omar Sery; Hana Tomaskova; Vladimir Janout
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2012-06       Impact factor: 1.245

Review 5.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

6.  Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index.

Authors:  Omar Šerý; Lýdia Hlinecká; Jana Povová; Ondřej Bonczek; Tomáš Zeman; Vladimír Janout; Petr Ambroz; Naim A Khan; Vladimir J Balcar
Journal:  J Neurol Sci       Date:  2016-01-15       Impact factor: 3.181

Review 7.  Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review.

Authors:  Omar Serý; Jana Povová; Ivan Míšek; Lukáš Pešák; Vladimir Janout
Journal:  Folia Neuropathol       Date:  2013       Impact factor: 2.038

Review 8.  Genes associated with Alzheimer's disease: an overview and current status.

Authors:  Mohan Giri; Man Zhang; Yang Lü
Journal:  Clin Interv Aging       Date:  2016-05-17       Impact factor: 4.458

Review 9.  The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.

Authors:  Arne De Roeck; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Acta Neuropathol       Date:  2019-03-22       Impact factor: 17.088

10.  CHAT gene polymorphism rs3810950 is associated with the risk of Alzheimer's disease in the Czech population.

Authors:  Alice Hálová; Jana Janoutová; Laura Ewerlingová; Vladimír Janout; Ondřej Bonczek; Tomáš Zeman; Tereza Gerguri; Vladimir J Balcar; Omar Šerý
Journal:  J Biomed Sci       Date:  2018-05-14       Impact factor: 8.410

View more
  4 in total

1.  Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease.

Authors:  Omar Šerý; Tomáš Zeman; Kateřina Sheardová; Martin Vyhnálek; Hana Marková; Jan Laczó; Jan Lochman; Petr Kralik; Kamila Vrzalová; Radka Dziedzinska; Vladimir J Balcar; Jakub Hort
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

2.  Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis.

Authors:  Virginia Veronica Visconti; Chiara Greggi; Ida Cariati; Beatrice Gasperini; Ambra Mastrogregori; Annalisa Botta; Umberto Tarantino
Journal:  Genes (Basel)       Date:  2022-04-07       Impact factor: 4.141

Review 3.  The Influence of Clusterin Glycosylation Variability on Selected Pathophysiological Processes in the Human Body.

Authors:  Ewa Janiszewska; Agnieszka Kmieciak; Monika Kacperczyk; Aleksandra Witkowska; Ewa Maria Kratz
Journal:  Oxid Med Cell Longev       Date:  2022-08-28       Impact factor: 7.310

4.  Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer's disease risk.

Authors:  Jin Ma; Shizheng Qiu
Journal:  Front Neurosci       Date:  2022-08-10       Impact factor: 5.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.